Condition: Acute Myeloid Leukaemia (AML) · Sponsor: Sohag University
this study will explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.
This description comes directly from the study's public registry record.
Eman I Abdelshakour, Asst lect · +201063901450 · Eman011065@med.sohag.edu.eg
Walaa G Mohamed, Lecturer
Always discuss trial participation with your own doctor first.
| Sohag university hospital | Sohag, Egypt | Recruiting |
| Sohag university | Sohag, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07244367